LobbyingFuture of Pharmacy Coalition lobbying by quarter
Future of Pharmacy Coalition's latest lobbying report covers Q2 2026, at $80K. The four quarters Q4 2025–Q3 2026 total $300K. Its first report covers Q4 2022; the issues it reports most are Health Issues.
Future of Pharmacy Coalition
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $300K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $120K | 1 |
| Q1 2023 | $140K | 1 |
| Q2 2023 | $140K | 1 |
| Q3 2023 | $140K | 1 |
| Q4 2023 | $140K | 1 |
| Q1 2024 | $140K | 1 |
| Q2 2024 | $110K | 1 |
| Q3 2024 | $110K | 1 |
| Q4 2024 | $110K | 1 |
| Q1 2025 | $110K | 1 |
| Q2 2025 | $110K | 1 |
| Q3 2025 | $110K | 1 |
| Q4 2025 | $110K | 1 |
| Q1 2026 | $110K | 1 |
| Q2 2026 | $80K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$1.8M · 15 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES14 reports
- SENATE14 reports
Firms it paid
| Firm | ||
|---|---|---|
| Alston & Bird | $1.8M | 15 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| JANE LUCAS | Special Assistant to the President, White House Office of Legislative Affairs; Principal Deputy Director, IOS-Office of Health Reform, HHS; Legislative Director, U.S. Senator John Thune. | Q2 2023 |
| MARK RAYDER | LA, Rep. Tom Latham; LA, Rep. Rodney Frelinghuysen; District Rep., Rep. Dean Gallo. | Q1 2023 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | Alston & Bird | $80K |
| 04/20for Q1 | Alston & Bird | $110K |
| 01/20for Q4 2025 | Alston & Bird | $110K |
| 25/10/20for Q3 2025 | Alston & Bird | $110K |
| 25/07/21for Q2 2025 | Alston & Bird | $110K |
| 25/04/21for Q1 2025 | Alston & Bird | $110K |
| 25/01/21for Q4 2024 | Alston & Bird | $110K |
| 24/10/21for Q3 2024 | Alston & Bird | $110K |
| 24/07/22for Q2 2024 | Alston & Bird | $110K |
| 24/04/22for Q1 2024 | Alston & Bird | $140K |
| 24/01/22for Q4 2023 | Alston & Bird | $140K |
| 23/10/20for Q3 2023 | Alston & Bird | $140K |
| 23/07/19for Q2 2023 | Alston & Bird | $140K |
| 23/04/20for Q1 2023 | Alston & Bird | $140K |
| 23/02/01for Q4 2022 | Alston & Bird | $120K |
| 23/01/30for Q4 2022 | Alston & Bird | Under $5,000 |